New scan aims to catch kidney cancer spread that others miss

NCT ID NCT07624578

Terminated Diagnosis Sponsor: Assistance Publique Hopitaux De Marseille Source: ClinicalTrials.gov ↗

First seen Jun 06, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This study planned to test a special PET-CT scan (68Ga-PSMA) in people newly diagnosed with advanced kidney cancer. The goal was to see if it could find small cancer spots that standard scans miss. However, the trial was withdrawn before any patients were enrolled, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

68Ga-PSMA PET-CT scan

What this could lead to

If successful, this scan could help doctors find small cancer spots earlier, leading to more timely treatment.

What could go wrong

This trial was withdrawn before it started, so no results are available. The scan is still experimental and may not prove better than current methods.

Conditions

The condition(s) this trial relates to.

Kidney Neoplasms renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY CANCERS